V2X, Inc. — FY 2023 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023. This is an annual filing; the provided text does not give a clear standalone fourth-quarter financial result. V2X provides mission, logistics, aerospace, training and technology services, primarily to U.S. government and defense customers. The company operates as one reportable segment and had about 16,000 employees and 6,200 subcontract personnel at year-end.
Financial performance and liquidity
| Metric | FY 2023 | FY 2022 |
|---|---|---|
| Revenue | $3,963.1 million | $2,890.9 million |
| Operating income / margin | $124.4 million / 3.1% | $55.8 million / 1.9% |
| Net loss | $22.6 million | $14.3 million |
| Operating cash flow | $188.0 million | $93.5 million |
| Capital expenditures | $25.0 million | $12.4 million |
- Cost of revenue was $3,628.3 million, or 91.6% of revenue, versus 89.8% in 2022. SG&A was $210.4 million (5.3% of revenue), down from $239.2 million; the 2022 figure included $39.9 million of acquisition-related costs.
- Revenue rose 37.1%, including $877.7 million attributed to the Vertex merger and the remainder to organic growth in legacy programs. Operating income rose 123.1%; favorable cumulative contract estimate adjustments contributed $22.7 million in 2023, compared with $13.3 million in 2022.
- Interest expense, net, increased to $122.4 million from $61.9 million, primarily due to merger-related debt. The company recorded a $22.3 million loss on extinguishment of debt and $4.2 million of other expense, largely related to fees on receivables sold. The $1.9 million income tax benefit left a $24.5 million pretax loss and a $22.6 million net loss.
- Cash, cash equivalents and restricted cash were $72.7 million at year-end, down from $116.1 million. Current assets were $874.9 million and current liabilities $840.2 million. The company reported $482.5 million of available capacity under its $500 million revolver, with $17.5 million of letters of credit and no revolver borrowings outstanding.
- Aggregate debt was $1,154.2 million at year-end. Term-loan effective rates were 9.51% on the first-lien facility and 8.41% on the 2023 term loan. The company had $345.3 million of interest-rate swaps outstanding. It reported compliance with debt covenants.
- Operating cash flow included a $72.7 million cash inflow from the sale of receivables through the MARPA facility. The company sold $1.395 billion of receivables during the year and incurred $4.0 million of net discount fees.
Material changes and business position
- The Vertex merger closed July 5, 2022; therefore, year-over-year revenue and operating comparisons include a substantial merger contribution. The company refinanced debt during 2023, including repayment of second-lien and other borrowings and replacement of the first-lien term loans.
- U.S. Army revenue was $1,633.5 million, or about 41% of total revenue, down from 46% in 2022. Navy revenue increased to $1,233.5 million from $713.7 million. The three largest contracts contributed approximately $1.1 billion, or 27.5% of 2023 revenue.
- Year-end backlog was $12.8 billion, including $2.8 billion funded, up from $12.3 billion total and $2.6 billion funded in 2022. The filing expects about 76% of remaining performance obligations of $3.6 billion to be recognized as revenue in 2024; backlog is subject to funding, options and termination risk.
Outlook, risks and unusual items
- No specific company revenue, earnings or cash-flow guidance is provided. Management describes long-term opportunity in mission-essential defense services, readiness, modernization and technology, but notes uncertainty around appropriations, continuing resolutions, contract awards and customer options.
- Management said it was monitoring inflation, labor and supply-chain costs, interest rates and geopolitical developments, and evaluating cost reductions and deleveraging. Cost-plus and cost-reimbursable work increased sequentially as a share of contract mix during 2023; firm-fixed-price work represented 41% of annual revenue and carries greater cost-overrun exposure.
- Material weakness in internal control: A Vertex subsidiary, representing approximately 25% of 2023 revenue, had deficiencies in IT general controls over user access for systems supporting financial reporting. Management and the auditor concluded internal control over financial reporting was ineffective at year-end; the auditor issued an adverse opinion on those controls. Management reported no material financial-statement errors or restatement and expected remediation before the end of 2024.
- Other key risks include dependence on U.S. government contracts and a few large programs, recompetes and termination rights, budget delays or cuts, high debt and variable-rate interest exposure, merger integration, workforce recruitment and retention, cybersecurity, international operations, and audits or claims under government contracts. Management did not expect pending legal matters or government audits described in the filing to have a material adverse effect.
Important facts for investors to verify
- Progress and independent testing of the planned remediation of the material weakness, including whether affected financial-reporting controls operate effectively.
- Whether backlog converts to funded work and revenue as expected, particularly the 2024 performance obligations and contract options for the major LOGCAP V task orders.
- Debt repayment, leverage and interest costs, covenant headroom, and the cash-flow contribution and ongoing cost of receivables sales.
- Underlying operating margins and cash generation excluding merger effects, favorable contract estimate adjustments and receivables-sale proceeds.
- Exposure to customer and contract concentration, appropriations timing, inflation, staffing needs and fixed-price cost overruns.